Moderna CEO Stéphane Bancel Buys 250,932 Shares Amid Market Rally and Pipeline Hype
Moderna CEO Stéphane Bancel’s March 1, 2026 buy of 250,932 shares signals steady insider confidence amid a mRNA rally and upcoming approvals.
6 minutes to read
MODERNA INC
Moderna CFO’s $53,000 PSU Vesting Sparks Investor Speculation Amid FDA Setback
Moderna CFO’s 2026 stock sale shows routine tax‑liquidation, not a sell‑off, underscoring insider moves as context rather than market signals.
4 minutes to read
Moderna CEO Bancel Boosts Stake by 2 % in Quiet PSU Vesting, Signals Confidence Ahead of Quarterly Results
Moderna CEO Stéphane Bancel’s recent PSU vesting boosts his stake by ~2 %—a bullish sign of leadership confidence amid regulatory setbacks and future mRNA pipeline growth.
4 minutes to read